Disagreement between PCR and serological diagnosis of Trypanosoma cruzi infection in blood donors from a Colombian endemic region.

Biomédica : revista del Instituto Nacional de Salud
Liliana Torcoroma García SánchezNelson Daza

Abstract

Chagas' disease is the leading cause of infectious myocarditis worldwide. This infection caused by Trypanosoma cruzi is usually life-long and asymptomatic; however, the third part of infected people can develop severe or even fatal cardiomyopathy. As the parasitemia in the chronic phase is both low-grade and intermittent, T. cruzi infection is principally detected by serology, although this method has sensitivity and specificity limitations. To determine the level of agreement between serologic and molecular tests in 658 voluntary blood donors from six provinces in the Colombian department of Santander. We evaluated an array of diagnostic technologies by cross-section sampling performing a serological double diagnostic test for T. cruzi antibody detection (Chagas III ELISA™, BiosChile Group, and ARCHITECT Chagas CMIA™, Abbott), and DNA detection by polymerase chain reaction (PCR). We collected the demographic, clinical, and epidemiological information of participants. The sample size was calculated using Epidat™ and the statistical analysis was done with Stata 12.1™. PCR was six times more sensitive in detecting T. cruzi infection than ELISA/CMIA with prevalence values of 1.8% (12/658) and 0.3% (2/658), respectively, and kappa=...Continue Reading

References

Sep 1, 1984·Revista Do Instituto De Medicina Tropical De São Paulo·S F BrénièreP Desjeux
Mar 11, 1999·The American Journal of Tropical Medicine and Hygiene·M L GomesE Chiari
Jun 8, 2002·Diagnostic Microbiology and Infectious Disease·Gláucia Elisete Barbosa MarconSandra Cecília Botelho Costa
Jan 15, 2004·Emerging Infectious Diseases·Oscar A SalomoneRoberto J Madoery
Oct 31, 2006·Memórias do Instituto Oswaldo Cruz·Antonio R L TeixeiraNancy R Sturm
Dec 8, 2009·Enfermedades infecciosas y microbiología clínica·María Flores-ChávezCarmen Cañavate
Sep 14, 2010·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Angelica M BatistaSandra C B Costa
Sep 26, 2012·Transfusion·Ester C SabinoUNKNOWN NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II) International Program
May 10, 2013·Advances in Experimental Medicine and Biology·Peter J HotezMaria E Bottazzi
Apr 20, 2014·PLoS Neglected Tropical Diseases·Janine M RamseyAlejandro Figueroa-Lara
Sep 2, 2015·The New England Journal of Medicine·Carlos A MorilloUNKNOWN BENEFIT Investigators
Feb 26, 2016·International Journal of Environmental Research and Public Health·Resign GundaSamson Mukaratirwa
Apr 8, 2016·Journal of Clinical Microbiology·Alba AbrasCarmen Muñoz
Jun 3, 2016·PLoS Neglected Tropical Diseases·Lucy J RobertsonPaul R Torgerson
May 21, 2017·Biomédica : revista del Instituto Nacional de Salud·Marlene ReyesVíctor Manuel Angulo
Dec 14, 2017·Clinics·Tania Regina Tozetto-MendozaMaria Aparecida Shikanai-Yasuda
May 1, 2017·Revista de salud pública·Mauricio Beltrán-DuránMaría I Bermúdez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.